Free accessResearch articleFirst published online 1998-7
Pathological Features of Spontaneous and Induced Tumors in Transgenic Mice Carrying a Human Prototype c-Ha- ras Gene Used for Six-Month Carcinogenicity Studies
To validate the transgenic (Tg) mouse carrying a human prototype c-Ha-ras gene (rasH2 mouse) as a model for short or medium-term carcinogenicity testing, 6-mo carcinogenicity studies using more than 30 chemicals, including carcinogens and noncarcinogens, have been performed. The results obtained so far indicate that rasH2 mice are generally much more susceptible to both mutagenic and nonmutagenic carcinogens than are non-Tg mice, pointing to advantageous application for detection of carcinogenic potential. In this review, histopathological features and diagnostic criteria for spontaneous and induced-tumors observed in our 6-mo carcinogenicity studies are described. Incidences of spontaneous tumors were generally low in rasH2 mice during the 6-mo studies, although values for lung adenomas and splenic hemangiosarcomas were higher than those in the control non-Tg mice. A few forestomach papillomas and skin papillomas were also observed in the control rasH2 mice. The target organs in rasH2 mice treated with known carcinogens were not always identical to those in the treated B6C3F1 mice in 2-yr carcinogenicity bioassays, with forestomach squamous cell tumors, lung alveolar epithelial tumors and/or hemangiosarcomas in the spleen observed in addition to some but not all of the lesions in target organs observed in non-Tg mice in long-term carcinogenicity bioassays. The results of the present histological study suggest that the lung, spleen and/or forestomach, where tumors are induced in rasH2 mice treated with known carcinogens, should be regarded as informative target organs in addition to the target organs reported in previous long-term carcinogenicity bioassays in rats and mice.
1. Ando K, Saitoh A, Hino O, Takahashi R, Kimura M, and Katsuki M (1992). Chemically induced forestomach papillomas in transgenic mice carrying mutant human c-Ha-ras transgenes. Cancer Res.. 52: 978–982.
2.
2. Dahl GA, Miller EC, and Miller JA (1980). Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate. Cancer Res.. 40: 1194–1203.
3.
3. Davies TS and Monro A (1995). Marketed pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol.. 14: 90–107.
4.
4. Diwan BA, Rice JM, Ohshima M, and Ward JM (1986). Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr. Carcinogenesis. 7: 215–220.
5.
5. Doi ST, Kimura M, and Katsuki M (1994). Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthra-cene causes tissue-specific tumors in mice. Jpn. J. Cancer Res.. 85: 801–807.
6.
6. Dragani TA, Manenti G, and Delia Porta G (1991). Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res.. 51: 6299–6303.
7.
7. Frith CH and Ward JM (1988). Color Atlas of Neoplastic and Nonneoplastic Lesions in Aging Mice.Elsevier, Amsterdam.
8.
8. Hawkins BL, Heniford BW, Ackermann DM, Leonberger M, Martinez SA, and Hendler SJ (1994). 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head & Neck. 16: 424–432.
9.
9. Hoffmann D, Rivenson A, Chung FL, and Hecht SS (1991). Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit. Rev. Toxicol.21:305–311.
10.
10. International Agency for Research on Cancer (1978). N-Nitroso-diethylamine. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 17, Some N-Nitroso Compounds. International Agency for Research on Cancer, Lyon, France, pp. 83–124.
11.
11. International Agency for Research on Cancer (1978). N-Nitroso-N-methylurea. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17, Some N-Nitroso Compounds. International Agency for Research on Cancer, Lyon, France, pp. 227–255.
12.
12. International Agency for Research on Cancer (1981). Cyclophosphamide. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 26, Some Antineoplastic and Immunosuppressive Agents.International Agency for Research on Cancer, Lyon, France, pp. 165–2022.
13.
13. International Agency for Research on Cancer (1987). Melphalan. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs.International Agency for Research on Cancer, Lyon, France, pp. 239–240.
14.
14. International Agency for Research on Cancer (1987). N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG). In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monograph.International Agency for Research on Cancer, Lyon, France, pp. 248–250.
15.
15. International Agency for Research on Cancer (1987). Phenacetin. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs.International Agency for Research on Cancer, Lyon, France, pp. 310–312.
16.
16. International Agency for Research on Cancer (1990). Ciclosporin. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 50, Pharmaceutical Drugs.International Agency for Research on Cancer, Lyon, France, pp. 77–114.
17.
17. Kawano R, Nishisaka T, Takeshima Y, Yonehara S, and Inai K (1995). Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane. Jpn. J. Cancer Res.. 86: 802–810.
18.
18. Kumagai H, Kawaura A, Furuya K, Izumi K, and Otsuka H (1982). Perianal lesions of BALB/c mice induced by 1,2-dimethylhydrazine dihydrochloride and methylazoxymethanol-acetate: Their classification and histogenesis. Gann. 73: 358–364.
19.
19. Malkinson AM (1982). The genetic basis of susceptibility to lung tumors in mice. Toxicology. 54: 241–271.
20.
20. Massey TE, Devereux TR, Maronpot RR, Foley JF, and Anderson MW (1995). High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1> (C57BL/6jÅBALB/cJ) mice. Carcinogenesis. 16: 1065–1069.
21.
21. Mitsumori K, Wakana S, Yamamoto S, Kodama Y, Yasuhara K, Nomura T, Hayashi Y, and Maronpot RR (1997). Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses on the induced tumors. Mol. Carcinog.. 20: 298–307.
22.
22. Monro AM (1996). Testing for carcinogenic potential. Proc. Int. Conf. Harmonization. 3: 261–268.
23.
23. National Toxicology Program (1992). Toxicology and Carcinogenesis Studies of Resorcinol (CAS: 108-46-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 403. National Toxicology Program, Research Triangle Park, North Carolina.
24.
24. National Toxicology Program (1993). TR-19 Bioassay of procarbazine for possible carcinogenicity (CAS: 336-70-1). Environ. Health Perspect.101(suppl. 1): 14.
25.
25. National Toxicology Program (1993). TR-47 Bioassay of 4,4'-thiodianiline for possible carcinogenicity (CAS: 139-65-1). Environ. Health Perspect.101(suppl. 1): 30.
26.
26. National Toxicology Program (1993). TR-58 Bioassay of Thio-TEPA for possible carcinogenicity (CAS: 52-24-4). Environ. Health Perspect.101(suppl. 1): 37–38.
27.
27. National Toxicology Program (1993). TR-80 Bioassay of 1,4-di-oxane for possible carcinogenicity (CAS: 123-91-1). Environ. Health Perspect.101(suppl. 1): 50.
28.
28. National Toxicology Program (1993). TR-116 Bioassay of p-anis-idine hydrochloride for possible carcinogenicity (CAS: 20265-97-8). Environ. Health Perspect.101(suppl. 1): 69.
29.
29. National Toxicology Program (1993). TR-142 Bioassay of p-cres-idine for possible carcinogenicity (CAS: 120-71-8). Environ. Health Perspect.101(suppl. 1): 81–82.
30.
30. National Toxicology Program (1993). TR-180 Bioassay of 4-nitro-O-phenylenediamine for possible carcinogenicity (CAS: 99-56-9). Environ. Health Perspect.101(suppl. 1): 101–102.
31.
31. National Toxicology Program (1993). TR-259 Carcinogenesis studies of ethyl acrylate (CAS: 140-88-5) in F344/N rats and B6C3F1 mice. Environ. Health Perspect.101(suppl. 1): 143.
32.
32. National Toxicology Program (1993). TR-276 Toxicology and carcinogenesis studies of 8-hydroxyquinoline (CAS: 148-24-3) in F344/N rats and B6C3F1 mice (feed studies). Environ. Health Perspect.101(suppl. 1): 152.
33.
33. National Toxicology Program (1993). TR-289 Toxicology and carcinogenesis studies of benzene (CAS: 71-43-2) in F344/N rats and B6C3F1 mice (gavage studies). Environ. Health Perspect.101(suppl. 1): 160–161.
34.
34. National Toxicology Program (1993). TR-320 Toxicology and carcinogenesis studies of rotenone (CAS: 83-79-4) in F344/N rats and B6C3F1 mice (feed studies). Environ. Health Perspect.101(suppl. 1): 186–187.
35.
35. National Toxicology Program (1993). TR-327 Toxicology and carcinogenesis studies of xylenes (mixed) (CAS: 1330-20-7) in F344/ N rats and B6C3F1 mice (gavage studies). Environ. Health Perspect.101(suppl. 1): 193–194.
36.
36. National Toxicology Program (1993). TR-362 Toxicology and carcinogenesis studies of 4-vinyL-1-cyclohexene diepoxide (CAS: 106-87-6) in F344/N rats and B6C3F1 mice (dermal studies). Environ. Health Perspect. 101(suppl. 1): 238-239.
37.
37. National Toxicology Program (1993). Toxicology and carcinogenesis studies of furfural (CAS: 98-01-1) in F344/N rats and B6C3F1 mice (gavage studies). Environ. Health Perspect.101(suppl. 1): 260–261.
38.
38. National Toxicology Program (1993). Toxicology and carcinogenesis studies of ethylene thiourea (CAS: 96-45-7) in F344 rats and B6C3F1 mice (feed studies). Environ. Health Perspect.101(suppl. 1): 264–266.
39.
39. Ogawa K, Imaida K, Masui T, Kawabe M, Hasegawa R, Kato K, Ito N, and Shirai T (1996). Chemically induced lung and forestom-ach neoplasias in transgenic mice carrying mutant forms of the human c-Ha-ras transgene. Carcinogenesis. 17: 341–345.
40.
40. Rao MS, Subbarao V, and Scarpelli DG (1987). Atypical acinar cell lesions of the pancreas in mice induced by 4-hydroxyaminoquin-oline-1-oxide. Int. J. Pancreatol.. 2: 1–10.
41.
41. Ryan J, Barker PE, Nesbitt MN, and Ruddle FH (1987). KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J. Natl. Cancer Inst.. 79: 1351–1357.
42.
42. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, and Katsuki M (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 5: 1195–1200.
43.
43. Stanley LA, Devereux TR, Foley J, Lord PG, Maronpot RR, Orton TC, and Anderson MW (1992). Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis. 13: 2427–2433.
44.
44. Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bio-assays using transgenic mouse models. Environ. Health Perspect.. 103: 942–950.
45.
45. Thurnherr N, Deschner EE, Stonehill EH, and Lipkin M (1973). Induction of adenocarcinomas of the colon in mice by weekly injection of 1,2-dimethylhydrazine. Cancer Res.. 33: 940–945.
46.
46. Turusov V and Mohr U (1994). Pathology of Tumours in Laboratory Animals, Vol. 2, Tumours of the Mouse.International Agency for Research on Cancer, Lyon, France.
47.
47. Urano K, Koizumi H, Nagase S, Watanabe Y, Jiang H, Nomura T, and Yamamoto S (1998). Rapid carcinogenic response of transgenic mice harboring the human prototype c-Ha-ras gene to various carcinogens. Prog. Clin. Biol. Res. (in press).
48.
48. Yamamoto S, Hayashi Y, Mitsumori K, and Nomura T (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab. Anim. Sci.. 47: 121–126.
49.
49. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, and Hayashi Y (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring human prototype c-Ha-ras gene than in control nontransgenic mice. Carcinogenesis. 17: 2455–2461.
50.
50. Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa K, Hayashi Y, and Nomura T (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. (in press).
